A
PTLA

Abingworth’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Abingworth’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-347,349
Closed -$13.2M – 18
2015
Q1 		$13.2M Sell
347,349
-583,333
-63% -$20M 5.61% 9
2014
Q4 		$26.4M Hold
930,682
– – 7.49% 4
2014
Q3 		$23.5M Sell
930,682
-310,230
-25% -$8.17M 14.07% 4
2014
Q2 		$36.2M Hold
1,240,912
– – 16.83% 3
2014
Q1 		$32.1M Hold
1,240,912
– – 17.73% 4
2013
Q4 		$32M Sell
1,240,912
-5
-0% -$122 24.08% 1
2013
Q3 		$33.2M Hold
1,240,917
– – 18.92% 3
2013
Q2 		$30.5M Buy
+1,240,917
New +$24.7M 23.47% 2

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Abingworth's PTLA Position: Q2 2015 in Review

Abingworth sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2015, closing a stake of 347,349 shares — an estimated $13.2M sold.

Abingworth first reported a position in PTLA in Q2 2013 and held it in 8 quarters. The position peaked at $36.2M in Q2 2014. 160 funds tracked by Wall St. Rank hold PTLA as of Q2 2015.

  • Abingworth reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Abingworth sold 347,349 Portola Pharmaceuticals, Inc. shares in Q2 2015, an estimated $13.2M.
  • Abingworth first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
  • Abingworth's Portola Pharmaceuticals, Inc. position peaked at $36.2M in Q2 2014.
  • 160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2015.

Based on Abingworth's 13F filing for Q2 2015, filed 14 Aug 2015.